Congenital Hypothyroidism Diagnosis and Treatment

Diagnostic Confirmation and Treatment

Repeating the newborn screening analyte, possibly in conjunction with related analytes, is sufficient for diagnosing congenital hypothyroidism because consistently abnormal levels can be indicative of clinical disease, as recommended by the American Academy of Pediatrics 1, 2

The American College of Medical Genetics recommends confirming the diagnosis by finding an elevated serum TSH and low T4 or free T4 level, and repeating the newborn screening analyte, possibly in conjunction with related analytes, is sufficient because consistently abnormal levels can be indicative of clinical disease 1, 2

For newborns with congenital hypothyroidism plus hypotonia, genetic testing for NKX2.1 (thyroid transcription factor) mutations or deletions is strongly recommended by the American Thoracic Society, as this specific combination suggests Brain-Lung-Thyroid syndrome and warrants immediate genetic evaluation 3, 4

The American Thoracic Society recommends immediate genetic evaluation for newborns with congenital hypothyroidism and hypotonia, as this combination is suggestive of Brain-Lung-Thyroid syndrome 3, 4

The American Academy of Family Physicians recommends starting levothyroxine immediately at 10-15 mcg/kg/day without waiting for confirmatory testing or symptom development to prevent irreversible neurocognitive damage in newborns with congenital hypothyroidism, as untreated congenital hypothyroidism leads to intellectual disabilities, growth failure, and permanent neuropsychologic defects 5, 6
Treatment initiated in the first several weeks of life can result in nearly normal intelligence and grossly normal neurocognitive outcomes in adulthood, with the American Academy of Family Physicians suggesting that treatment must begin within the first 2 weeks of life to prevent mental retardation and optimize neurocognitive outcomes 5, 6